Advances in Pharmacoepidemiology and Drug Safety

Menat U, Desai CK, Panchal JR, Shah AN. An evaluation of trigger tool method for adverse drug reaction monitoring at a tertiary care teaching hospital. Perspectives in Clinical Research. 2021 Jan;12(1):33.

Myemba DT, Bwire GM, Sambayi G, Maganda BA, Njiro BJ, Ndumwa HP, Majani F, Kunambi PP, Matee MI. Clinical characteristics and treatment outcomes of patients with MDR tuberculosis in Dar Es Salaam region, Tanzania. JAC-Antimicrobial Resistance. 2020 Dec;2(4):dlaa108.

Alemu A, Bitew ZW, Worku T, Gamtesa DF, Alebel A. Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis. PloS one. 2021 Jun 28;16(6):e0253848.

Andargie A, Molla A, Tadese F, Zewdie S. Extra Pulmonary Drug Resistant Tuberculosis Patients Were Less Likely to Lost From Follow-up: a Systematic Review and Meta-analysis.

Bade AB, Mega TA. Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study. PloS one. 2020 Nov 9;15(11):e0241684.

Kodali G, Seru G. International Journal of Research in Pharmacology & Pharmacotherapeutics.

Andargie A, Molla A, Tadese F, Zewdie S. Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: A systematic review and meta-analysis. PloS one. 2021 Mar 18;16(3):e0248687.

Sawarkar A, Sharma RK, Gautam V, Shramankar K, Dinodia N. Pharmacovigilance: Present status and future perspectives. The Pharma Innovation Journal. 2019;8(8):84-92.

Wotale TW, Terefe AN, Fufa JA. Modeling Time to Death of Patients with Multidrug-Resistant Tuberculosis at Saint Peter’s Specialized Hospital. Journal of Research in Health Sciences. 2021 May 19.

Menat UJ, Desai CK, Shah MK, Shah AN. Evaluation of trigger tool method for adverse drug reaction reporting by nursing staff at a tertiary care teaching hospital. International Journal of Basic & Clinical Pharmacology. 2019 Jun;8(6):1139.

Kamarapu P. Epidemiology: Open Access. trials. 2016;45:51.

Muluneh MA, Zeru AB, Derseh BT, Molla Kebede A. Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia. Canadian Journal of Infectious Diseases and Medical Microbiology. 2021 Sep 6;2021.

Ketema DB, Alene M, Assemie MA, Yismaw L, Merid MW. Risk factors for mortality among drug-resistant tuberculosis patients registered for drug-resistant treatment in Amhara region, Ethiopia: a historical cohort study. Archives of Public Health. 2020 Dec;78(1):1-9.

Kamarapu P. Epidemiology: Open Access. trials. 2016;45:51.

Alemu A, Bitew ZW, Worku T. Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in Ethiopia: a systematic review and meta-analysis. International Journal of Infectious Diseases. 2020 Jul 6.

Menat UJ, Desai CK, Shah MK, Shah AN. Evaluation of trigger tool method for adverse drug reaction reporting by nursing staff at a tertiary care teaching hospital. International Journal of Basic & Clinical Pharmacology. 2019 Jun;8(6):1139.

Bajehson M, Musa BM, Gidado M, Nsa B, Sani U, Habibu AT, Aliyu I, Hussaini T, Yusuf A, Gida Y. Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria. PloS one. 2019 Nov 19;14(11):e0225165.

Babu LP, Babu JV, George S, Robin N, Jose J. Adverse Drug Reactions in Drug-Resistant Tuberculosis Management: A Clinical Approach. Indian Journal of Pharmacy Practice. 2021 Apr;14(2):73.

Sawarkar A, Sharma RK, Gautam V, Shramankar K, Dinodia N. Pharmacovigilance: Present status and future perspectives. The Pharma Innovation Journal. 2019;8(8):84-92.

Kumar A, Khan H. Signal detection and their assessment in pharmacovigilance. Open Pharmaceutical Sciences Journal. 2015 Dec 17;2(1).